http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101161789-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
| filingDate | 2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101161789-B1 |
| titleOfInvention | New Biomarkers and Their Uses for Liver Cancer |
| abstract | The present invention relates to the identification of genes that can act as new liver cancer diagnostic markers, and to the diagnosis and prognosis of liver cancer using the same. More specifically, liver cancer diagnostic markers S100P, NK4, CCL20, CSPG2, PLAU, MMP12, ESM-1, ABHD7, HCAPG, CXCL-3, Col5A2, MAGEA, GSN, CDC2, CST1, MELK, ATAD2, FAP and MSN The present invention relates to a diagnostic kit for diagnosing and prognostic liver cancer using an agent for measuring the expression level of any one or more genes selected from the group consisting of and / or a method for diagnosing and prognostic liver cancer using the same. As extracted from normal liver tissues and liver cancer tissues taken from the same liver cancer patient of the present invention, the markers have been greatly improved in accuracy and reliability as markers for liver cancer. Using the marker of the present invention can accurately diagnose and prognostic liver cancer.n n n n Liver cancer, marker, diagnostic, S100P, NK4, CCL20, CSPG2, PLAU, MMP12, ESM-1, ABHD7, HCAPG, CXCL-3, Col5A2, MAGEA, GSN, CDC2, CST1, MELK, ATAD2, FAP, MSN, AFP, CRP |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014148780-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160043419-A |
| priorityDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 563.